New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 3, 2014
07:06 EDTITCIIntra-Cellular announces initiation of Phase I/II clinical trial for ITI-007
Intra-Cellular announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease. The commencement of this study marks an important milestone in our strategy to develop low doses of ITI-007 for the treatment of behavioral disturbances associated with dementia and related disorders.
News For ITCI From The Last 14 Days
Check below for free stories on ITCI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ITCI

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use